BB Liquidatin a News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.03.24	Blockbuster-Status schon 2024: Krebsmedikament soll Bayer Milliarden in die Kasse spülen (N-TV)
21.03.24	Tired of Streaming? Free Blockbuster Libraries Offer an Alternative. (New York Times)
19.03.24	Is Novo Nordisk on the Verge of Another Blockbuster Drug? (MotleyFool)
17.03.24	Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock? (MotleyFool)
15.03.24	Newly Diagnosed Cervical Cancer Patients - Merck's Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival (Benzinga)
15.03.24	Reddit removes CEO pay incentives in signal of reduced hopes for IPO (Financial Times)
03.03.24	Better Blockbuster-Drug Stock: Novo Nordisk vs. Eli Lilly (MotleyFool)
01.03.24	Taylor Swift, ‘3 Body Problem,’ ‘Shōgun’ highlight a blockbuster March for streaming (MarketWatch)
28.02.24	Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss (Benzinga)
21.02.24	Former Blockbuster and 7-Eleven CEO James Keyes on Netflix, AI, Education, and More (MotleyFool)
20.02.24	AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira (MarketWatch)
07.02.24	Shein seeks Chinese regulators’ tacit approval for US public offering (Financial Times)
07.02.24	Shein seeks Chinese regulators’ tacit approval for US public offering (Financial Times)
02.02.24	Blockbuster Jobs Report Backs Up Fed’s Patience as It Waits to Cut Rates (New York Times)
31.01.24	GSK lifts long-term outlook following launch of blockbuster vaccine in 2023 (MarketWatch)
29.01.24	GSK’s new RSV jab set to achieve blockbuster status (Financial Times)
19.01.24	Amgen's Blockbuster Osteoporosis Drug Prolia Flagged With FDA Strictest Warning (Benzinga)
17.01.24	Eli Lilly's Blockbuster Diabetes Drug Mounjaro Set To Enter New Markets Amid Manufacturing Boost (Benzinga)
16.01.24	Cholesterol Player NewAmsterdam Pharma's Obicetrapib Is A Potential Blockbuster In Cardiovascular Market: Bullish Analyst Says (Benzinga)
23.12.23	Tech Giants In Talks: Synopsys Reportedly Aims For Blockbuster Acquisition Of Ansys In 2024 (Benzinga)
20.12.23	PlayStation sales and blockbuster games propel console market back to growth (Financial Times)
08.07.22	Pre-market Movers: DBD, SRG, ISIG, UPST, CSSE… (RTTNews)
02.07.22	Brickell Biotech Announces 1-to-45 Reverse Stock Split, Stock Tanks (RTTNews)
18.01.22	Pre-market Movers: BBI, SXTC, IO, SBEV, SRGA… (RTTNews)
28.10.21	Pre-market Movers: IFRX, CWBR, FUTU, MRAI, GRTX… (RTTNews)
08.01.21	Pre-market Movers In Healthcare Sector: MRUS, OGEN, JAGX, CVAC, SRPT… (RTTNews)
06.01.21	Pre-market Movers In Healthcare Sector: ISR, GHSI, NMTR, CHEK, BBI… (RTTNews)
30.11.20	Pre-market Movers In Healthcare Sector: ORMP, VSTM, MRNA, COCP, SYBX... (RTTNews)
23.10.20	Pre-market Movers In Healthcare Sector: SAVA, KTOV, PRVL, IMMP, GILD, ITRM, BBI… (RTTNews)
08.09.20	AnGes, Brickell Ink Deal To Develop DNA Vaccine Candidate For COVID-19 - Quick Facts (RTTNews)
19.02.20	BBI Awaits Data In Q2, BLPH Breathes Easy, Big Day For BXRX Tomorrow (RTTNews)
25.01.20	Intel's blockbuster results lift shares to dotcom peak, fire up sector (Reuters)
22.01.20	J&J misses revenue estimates as blockbuster drugs disappoint (Reuters)
06.12.19	Dollar shines after blockbuster U.S. jobs report; data backs steady Fed (Reuters)
25.11.19	Charles Schwab to buy TD Ameritrade in $26-billion blockbuster brokerage deal (Reuters)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swiss Re	133.55	4.50 %	K V
Swiss Life Hldg	693.60	0.93 %	K V
Zurich Insur Gr	552.80	0.91 %	K V
Kuehne+Nagel Int	206.60	0.78 %	K V
Sonova Hldg	294.00	0.58 %	K V
Sika	228.20	-1.04 %	K V
Part Grp Hldg	1’264.50	-1.56 %	K V
Geberit	538.20	-1.61 %	K V
Alcon	75.22	-1.75 %	K V
Lonza Grp	532.80	-2.81 %	K V

Nachrichten zu BB Liquidating Inc. (A)

Aktien Top/Flop

Meistgelesene Nachrichten